| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/PR.2014.170 |
| P698 | PubMed publication ID | 25314581 |
| P50 | author | Carlo Agostoni | Q43871064 |
| Marta Olivares | Q58316364 | ||
| Yolanda Sanz | Q60388687 | ||
| Ángela Moya-Pérez | Q85784561 | ||
| P2093 | author name string | Marta Olivares | |
| Ángela Moya-Pérez | |||
| P2860 | cites work | Low incidence of spontaneous type 1 diabetes in non-obese diabetic mice raised on gluten-free diets is associated with changes in the intestinal microbiome | Q21132451 |
| Toward defining the autoimmune microbiome for type 1 diabetes | Q24629032 | ||
| The "perfect storm" for type 1 diabetes: the complex interplay between intestinal microbiota, gut permeability, and mucosal immunity | Q24645048 | ||
| Innate immunity and intestinal microbiota in the development of Type 1 diabetes | Q24647312 | ||
| Mechanisms underlying the resistance to diet-induced obesity in germ-free mice | Q24676006 | ||
| Diet, gut microbiota and immune responses | Q28301332 | ||
| Bacteroides uniformis CECT 7771 ameliorates metabolic and immunological dysfunction in mice with high-fat-diet induced obesity | Q28481575 | ||
| Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns | Q29547261 | ||
| A metagenome-wide association study of gut microbiota in type 2 diabetes | Q29547726 | ||
| Involvement of tissue bacteria in the onset of diabetes in humans: evidence for a concept | Q42619039 | ||
| Gut microbiota composition is associated with body weight, weight gain and biochemical parameters in pregnant women | Q43141586 | ||
| Geographical variation of presentation at diagnosis of type I diabetes in children: the EURODIAB study. European and Dibetes | Q44276255 | ||
| Ultrastructural mucosal alterations and increased intestinal permeability in non-celiac, type I diabetic patients. | Q44769295 | ||
| Interplay between weight loss and gut microbiota composition in overweight adolescents. | Q46038516 | ||
| Molecular characterisation of the faecal microbiota in patients with type II diabetes | Q46864209 | ||
| Differences in the gut microbiota of healthy children and those with type 1 diabetes. | Q51164852 | ||
| Bifidobacterium CECT 7765 improves metabolic and immunological alterations associated with obesity in high-fat diet-fed mice. | Q51537577 | ||
| Cesarean delivery is associated with celiac disease but not inflammatory bowel disease in children. | Q51770865 | ||
| Early differences in fecal microbiota composition in children may predict overweight. | Q53219254 | ||
| Caesarean section is associated with an increased risk of childhood-onset type 1 diabetes mellitus: a meta-analysis of observational studies. | Q55048787 | ||
| Diagnosis and Classification of Diabetes Mellitus | Q56001184 | ||
| Association between rotavirus infection and pancreatic islet autoimmunity in children at risk of developing type 1 diabetes | Q74102320 | ||
| Increased intestinal permeability precedes clinical onset of type 1 diabetes | Q79211266 | ||
| Antibiotic treatment partially protects against type 1 diabetes in the Bio-Breeding diabetes-prone rat. Is the gut flora involved in the development of type 1 diabetes? | Q79830050 | ||
| Gut microbiota from twins discordant for obesity modulate metabolism in mice | Q29614796 | ||
| Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5 | Q29615053 | ||
| Richness of human gut microbiome correlates with metabolic markers | Q29617365 | ||
| Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability | Q29617378 | ||
| Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults | Q29617576 | ||
| Human intestinal microbiota composition is associated with local and systemic inflammation in obesity | Q31113843 | ||
| The incidence of type-1 diabetes in NOD mice is modulated by restricted flora not germ-free conditions | Q33833767 | ||
| Dissecting the in vivo metabolic potential of two human gut acetogens | Q33991325 | ||
| Dietary intervention impact on gut microbial gene richness | Q34037982 | ||
| Gut microbiome metagenomics analysis suggests a functional model for the development of autoimmunity for type 1 diabetes | Q34063601 | ||
| Gut microbiota is a key modulator of insulin resistance in TLR 2 knockout mice | Q34097751 | ||
| Obesity, diabetes, and gut microbiota: the hygiene hypothesis expanded? | Q34153569 | ||
| Influence of milk-feeding type and genetic risk of developing coeliac disease on intestinal microbiota of infants: the PROFICEL study. | Q34154669 | ||
| Gut metagenome in European women with normal, impaired and diabetic glucose control | Q34347521 | ||
| Coxsackievirus B1 is associated with induction of β-cell autoimmunity that portends type 1 diabetes | Q34366531 | ||
| High fat diet-induced gut microbiota exacerbates inflammation and obesity in mice via the TLR4 signaling pathway | Q34455345 | ||
| Endotoxemia is associated with an increased risk of incident diabetes | Q34507178 | ||
| Zonulin upregulation is associated with increased gut permeability in subjects with type 1 diabetes and their relatives. | Q34518641 | ||
| Gut microbiota in children with type 1 diabetes differs from that in healthy children: a case-control study | Q34596660 | ||
| Anti-infectious antibodies and autoimmune-associated autoantibodies in patients with type I diabetes mellitus and their close family members | Q35003272 | ||
| Energy-balance studies reveal associations between gut microbes, caloric load, and nutrient absorption in humans | Q35080321 | ||
| Establishment of intestinal microbiota during early life: a longitudinal, explorative study of a large cohort of Danish infants | Q35105315 | ||
| Long term effect of gut microbiota transfer on diabetes development | Q35157830 | ||
| Microbiota, inflammation and obesity. | Q35201601 | ||
| Celiac disease associated with type 1 diabetes mellitus | Q35725847 | ||
| Metabolic adaptation to a high-fat diet is associated with a change in the gut microbiota | Q35799019 | ||
| Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/- mice | Q36087089 | ||
| The marriage of nutrigenomics with the microbiome: the case of infant-associated bifidobacteria and milk | Q37590649 | ||
| The therapeutic potential of manipulating gut microbiota in obesity and type 2 diabetes mellitus | Q37910974 | ||
| Understanding the role of gut microbes and probiotics in obesity: how far are we? | Q38059355 | ||
| Does breastfeeding influence the risk of developing diabetes mellitus in children? A review of current evidence | Q38154031 | ||
| Immune modulation in humans: implications for type 1 diabetes mellitus. | Q38182297 | ||
| Functional metagenomic investigations of the human intestinal microbiota | Q38729839 | ||
| Sirtuin inhibition attenuates the production of inflammatory cytokines in lipopolysaccharide-stimulated macrophages. | Q39370607 | ||
| The pioneer gut microbiota in human neonates vaginally born at term-a pilot study | Q39744092 | ||
| Oral probiotic administration induces interleukin-10 production and prevents spontaneous autoimmune diabetes in the non-obese diabetic mouse | Q40409987 | ||
| Gut-derived lipopolysaccharide augments adipose macrophage accumulation but is not essential for impaired glucose or insulin tolerance in mice | Q42351778 | ||
| P433 | issue | 1-2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | microbiome | Q1330402 |
| metabolic disease | Q2351083 | ||
| P304 | page(s) | 236-244 | |
| P577 | publication date | 2014-10-14 | |
| P1433 | published in | Pediatric Research | Q7159215 |
| P1476 | title | Understanding the role of gut microbiome in metabolic disease risk | |
| P478 | volume | 77 |
| Q52648360 | A poly-herbal blend (Herbagut®) on adults presenting with gastrointestinal complaints: a randomised, double-blind, placebo-controlled study. |
| Q90265249 | Alterations in Gut Microbiota by Statin Therapy and Possible Intermediate Effects on Hyperglycemia and Hyperlipidemia |
| Q78878946 | An Apple a Day: Which Bacteria Do We Eat With Organic and Conventional Apples? |
| Q47130145 | Antibiotic-Induced Alterations in Gut Microbiota Are Associated with Changes in Glucose Metabolism in Healthy Mice |
| Q35692948 | CX3CR1 is a gatekeeper for intestinal barrier integrity in mice: Limiting steatohepatitis by maintaining intestinal homeostasis |
| Q60950163 | Causal Relationship between Diet-Induced Gut Microbiota Changes and Diabetes: A Novel Strategy to Transplant Faecalibacterium prausnitzii in Preventing Diabetes |
| Q91777080 | Co-existence of Network Architectures Supporting the Human Gut Microbiome |
| Q35930349 | Delivery Mode, Duration of Labor, and Cord Blood Adiponectin, Leptin, and C-Reactive Protein: Results of the Population-Based Ulm Birth Cohort Studies |
| Q64116337 | Does exercise impact gut microbiota composition in men receiving androgen deprivation therapy for prostate cancer? A single-blinded, two-armed, randomised controlled trial |
| Q90004775 | Downregulation of IL-18 Expression in the Gut by Metformin-induced Gut Microbiota Modulation |
| Q37704533 | Effects of Gliadin consumption on the Intestinal Microbiota and Metabolic Homeostasis in Mice Fed a High-fat Diet |
| Q47279426 | Engineering chemical interactions in microbial communities. |
| Q37106506 | Evaluation of differential effects of metformin treatment in obese children according to pubertal stage and genetic variations: study protocol for a randomized controlled trial |
| Q51417451 | FUT2 genotype and secretory status are not associated with fecal microbial composition and inferred function in healthy subjects. |
| Q49769640 | Gut Microbiota Dysbiosis Drives and Implies Novel Therapeutic Strategies for Diabetes Mellitus and Related Metabolic Diseases |
| Q37370213 | Impact of Microbiome on Ocular Health |
| Q34463765 | Ketosis, ketogenic diet and food intake control: a complex relationship |
| Q91942374 | Metagenomics in ophthalmology: Hypothesis or real prospective? |
| Q55384385 | Modulation of Active Gut Microbiota by Lactobacillus rhamnosus GG in a Diet Induced Obesity Murine Model. |
| Q38916481 | Modulation of type 1 and type 2 diabetes risk by the intestinal microbiome |
| Q37275280 | Natural history of the infant gut microbiome and impact of antibiotic treatment on bacterial strain diversity and stability |
| Q90334692 | New Insights into Immunotherapy Strategies for Treating Autoimmune Diabetes |
| Q55310980 | Shared and Distinct Features of Human Milk and Infant Stool Viromes. |
| Q50532218 | Synthetic Biology Approaches to Engineer Probiotics and Members of the Human Microbiota for Biomedical Applications. |
| Q53409142 | The Biological Clock: A Pivotal Hub in Non-alcoholic Fatty Liver Disease Pathogenesis. |
Search more.